1 / 59

Case definitions of diseases and syndromes under surveillance

Case definitions of diseases and syndromes under surveillance. IDSP training module for state and district surveillance officers Module 5. Learning objectives. Describe why case definitions for diseases are crucial for disease surveillance

Download Presentation

Case definitions of diseases and syndromes under surveillance

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Case definitions of diseases and syndromes under surveillance IDSP training module for state and district surveillance officers Module 5

  2. Learning objectives • Describe why case definitions for diseases are crucial for disease surveillance • List the diseases/syndromes under surveillance in state and define what is probable /suspected /confirmed case • List laboratory criteria for the diseases under surveillance • Describe correctly why trigger levels are specified and the response to trigger level 1 and 2

  3. Key principles of the Integrated Disease Surveillance Programme • Monitor a limited number of health conditions • Integrate surveillance activities under various programmes • Use laboratories in surveillance • Set up of district and state surveillance units • Involve private sector and medical colleges • Take advantage of information technologies

  4. Types of case definitions in use More specificity

  5. Rationale for the use of case definitions • Uniformity in case reporting at district, state and national level • Use of the same criteria by reporting units to report cases • Compatibility with the case definitions used in WHO recommended surveillance standards • Allow international information exchanges

  6. Levels of case definitions • Suspect case • A case that meets the clinical case definition • Probable case • A suspect case that is diagnosed by a medical officer • Confirmed case • A suspect case that is laboratory confirmed

  7. Epidemiologically linked case • The patient had contact with one or more persons who: • Have/had the disease • Have been exposed to a point source of infection • Transmission of the agent by the usual modes of transmission is plausible

  8. Triggers • Threshold for diseases under surveillance that trigger pre-determined actions at various levels • Based upon the number of cases in weekly report • Trigger levels depend on: • Type of disease • Case fatality (Death / case ratio) • Number of evolving cases • Usual trend in the region

  9. Levels of response to different triggers

  10. Conditions under regular surveillance

  11. Other conditions under surveillance

  12. Malaria: Clinical case description • Any patient with fever with any of the following: • Chills, sweating, jaundice or splenomegaly • Convulsions, coma, shock, pulmonary edema and death may be associated in severe cases

  13. Laboratory criteria for malaria diagnosis • Demonstration of malaria parasite on blood film • Positive rapid diagnostic test for malaria

  14. Malaria case classification • Suspect • Any case of fever • Probable • Case that meets the clinical case definition • Confirmed • A suspected/probable case that is laboratory-confirmed

  15. Malaria: Outbreak definition* • Trigger 1 • Single case of smear positive in an area where malaria was not present for a minimum of three months • Slide positivity rate doubling over last three months • Single death from clinically /microscopically proven malaria • Single falciparum case of indigenous origin in a free region • Trigger 2: • Two fold rise in malaria in the region over last 3 months • More than five cases of falciparum of indigenous origin * State may set their own triggers

  16. Cholera: Clinical case description • In an area where the disease is not known to be present • Severe dehydration or death from acute watery diarrhoea in a patient aged 5 years or more • In an area where cholera is endemic • Acute watery diarrhea, with or without vomiting in a patient aged 5 years or more • In an area where there is a cholera epidemic • Acute watery diarrhoea, with or without vomiting, in any patient

  17. Laboratory criteria for cholera diagnosis • Isolation of Vibrio cholera O1 or O139 from stools in any patient with diarrhea 

  18. Cholera case classification • Suspect case • A case that meets the clinical case definition • Probable case • A suspect case that is diagnosed by the medical officer • Confirmed case • A suspected case that is laboratory- confirmed

  19. Cholera: Outbreak definitions • Trigger 1 • A single case of cholera / epidemiologically linked cases of diarrhea • A case of severe dehydration / death due to diarrhea in a patient of >5 years of age • Clustering of cases in a particular village / urban ward where more than 10 houses have at least one case of loose stools irrespective of age per 1000 population • Trigger 2 • More than 20 cases of diarrhea in a village/geographical area of 1000 population

  20. Typhoid fever: Clinical case description • Any person with fever for >1 week • Any TWO of the following: • Toxic look • Coated tongue • Relative bradycardia • Splenomegaly

  21. Laboratory criteria for diagnosis of typhoid fever • Serology • Typhi dot / Widal test positive • Isolation of organism from clinical specimen (blood)

  22. Typhoid fever: Case classification • Probable case • Case of fever diagnosed by medical officer that is compatible with: • Clinical case description • Typhi dot/Widal test positive • Epidemiological link to a confirmed case • Confirmed case • Probable case that is laboratory confirmed by: • Isolation of S. typhi/ S. paratyphi from blood • Four fold rise in antibody titres in paired sera 10 days apart

  23. Typhoid fever: Outbreak definitions • Trigger 1 • More than 30 cases in a week from the entire primary health centre area • 5 or more cases per week from one sub-centre of 5,000 population • More than 2 cases from a single village/urban ward/1000 population • Clustering of cases of fever • Trigger 2 • More than 60 cases from a primary health centre or more than 10 cases from a sub-center

  24. Tuberculosis: Case classification • Suspect • Any person with cough >3 weeks • Probable • Patient with symptoms suggestive of tuberculosis (cough >3 wks with or without fever) diagnosed by medical officer as tuberculosis with or without radiological signs consistent with pulmonary tuberculosis • Confirmed • A case that meets clinical case definition and that is positive for laboratory criteria

  25. Measles clinical case definition • Any person with • Fever • Maculo-papular rash lasting for more than 3 days • Cough or coryza or conjunctivitis

  26. Laboratory criteria for measles diagnosis • Presence of measles specific IgM antibodies • Isolation of measles virus • At least a four fold increase in antibody titres

  27. Measles: Case classification • Suspect • Any case with fever and rash • Probable • Suspect case who is diagnosed as measles by medical officer on basis of clinical case description • Confirmed • A probable case that is: • Laboratory confirmed • Linked epidemiologically to a laboratory confirmed case

  28. Polio: Clinical description of acute flaccid paralysis • Any child: • Aged <15 years • Acute onset of flaccid paralysis for which no obvious cause (such as serve trauma or electrolyte imbalance) is found • OR: • Paralytic illness in a person of any age in which polio is suspected

  29. Laboratory criteria for polio diagnosis • Isolation of a wild poliovirus from stool specimen

  30. Polio case classification • Suspect • Syndromic case of acute flaccid paralysis • Probable • Epidemiologically linked case • Confirmed • Suspected case that is laboratory confirmed

  31. Polio trigger • Even a single case will trigger outbreak investigations

  32. Plague: Clinical case description • Rapid onset of fever,chills, headache, severe malaise with: • Bubonic form: • Extreme painful swelling of lymph nodes in axilla, groin and neck (bubos) • Pneumonic form: • Cough with blood stained sputum, chest pain and dyspnea • Septicemic form: • Toxic changes in patient

  33. Laboratory criteria for plague diagnosis • Giemsa smear positive • Direct fluorescent antibody testing of smears • PCR test • 4 fold increase in antibody titres against F1 antigen • Isolation of the bacteria by culture

  34. Criteria to define a probable case of plague • A case consistent with clinical case description with history of rat fall • Y.pestis F1 antigen detected in clinical materials by direct fluorescent antibody testing or by some other standardized antigen detection method • Isolate from a clinical specimen demonstrates biochemical reactions consistent with Y.pestis or PCR positivity • A single serum specimen is found positive for diagnostic levels of antibodies to Y.pestis F1 antigen, not explainable on the basis of prior infection or immunization with an epidemiological link with a confirmed case

  35. Criteria to define a confirmed case of plague • Probable case that is laboratory-confirmed • Isolate identified as Y. pestis by phage lysis or cultures • OR • A significant (4-fold) change in antibody titres to the F1 antigen in paired serum specimens

  36. Plague: Triggers • Trigger 1 • Rat fall • Trigger 2 • At least 1 probable case of plague in community

  37. Japanese encephalitis: Clinical case description • Febrile illness of variable severity associated with neurological symptoms ranging from headache to meningitis or encephalitis • Symptoms can include: • Headache, fever, meningeal signs, stupor, disorientation, coma, tremors, paresis (generalized), hypertonia, loss of coordination • The encephalitis cannot be distinguished clinically from other central nervous system infections

  38. Presumptive laboratory criteria for Japanese encephalitis diagnosis • Detection of an acute phase anti-viral antibody response through one of the following: • Elevated and stable serum antibody titres of JE virus through ELISA, hemagglutination or virus neutralization assay • IgM antibody to the virus in serum (Appears after 1 week of disease)

  39. Confirmatory laboratory criteria for Japanese encephalitis diagnosis • Detection of JE virus, antigen or genome in tissue, blood or other body fluid by immuno-chemistry or immuno-fluorescence or PCR, • JE virus-specific IgM in the CSF • Fourfold or greater rise in JE virus-specific antibody in paired sera through IgM /IgG, ELISA, haemagglutination inhibition test or virus neutralization test

  40. Japanese encephalitis: Case classification • Suspect • Any case with fever of acute onset and altered consciousness/ convulsions and change in behaviour • Probable • Any suspected cases diagnosed as Japanese encephalitis by the medical officer • Any suspect case with presumptive laboratory results • A case of fever epidemiologically linked with a proven Japanese encephalitis case • Confirmed • A suspect or probable case confirmed by confirmatory laboratory tests

  41. Japanese encephalitis: Triggers • Trigger 1 • Clustering of two or more similar case from a locality in one week • Trigger 2 • More than four cases from a PHC (30,000 population) in one week

  42. Dengue fever: Clinical case description • An acute febrile illness of 2-7 days duration with 2 or more of the following: • Headache • Retro-orbital pain • Myalgia • Arthralgia • Rash • Hemorrhagic manifestations • Leucopenia

  43. Probable case classification of Dengue fever • A case diagnosed by medical officer as Dengue fever based on the clinical case definition • OR • A case with fever with blood negative for malaria and not responding to anti-malarials • WITH • Supportive serology (reciprocal hemagglutination-inhibition antibody titre, comparable IgG EIA titre or positive IgM antibody test in late acute or convalescent-phase serum specimen) • Epidemiological link with a confirmed case • High vector density

  44. Confirmed case of Dengue fever • Isolation of the dengue virus from serum, plasma, leukocytes or autopsy samples • Demonstration of a four fold or greater change in reciprocal IgG or IgM antibody titres to one or more dengue virus antigens • Demonstration of dengue virus antigen in autopsy tissue • Detection of viral genomic sequences in autopsy tissue, serum or CSF samples

  45. Dengue hemorrhagic fever • Probable or confirmed case of Dengue fever with • One or more criteria of hemorrhagic tendency • Positive tourniquet test • Petichiae, ecchymoses or purpura • Bleeding from mucosa / GIT/ injection site • Thrombocytopenia • Evidence of plasma leakage as manifested by: • Pleural effusion • Ascitis • Hypo-proteinemia

  46. Dengue shock syndrome • A case of Dengue hemorrhagic fever • AND • Evidence of circulatory failure manifested by rapid and weak pulse and narrow pulse pressure (<20 mmHg) or hypotension

  47. Dengue: Triggers • Trigger 1 • Clustering of two similar case of probable Dengue fever in a village • Single case of Dengue hemorrhagic fever • Trigger 2 • More than four cases of Dengue fever in a village with population of about 1000

  48. Acute viral hepatitis: Clinical case description • Acute jaundice (Yellow sclera/skin) • Dark urine • Anorexia, malaise • Extreme fatigue • Right upper quadrant tenderness

  49. Laboratory criteria for acute viral hepatitis diagnosis • HAV • IgM HAV • HBV • Positive for HBsAg and IgM anti-HBc • HCV • Positive anti-HCV • HDV • Positive for HBsAg and anti-HDV • HEV • Positive for IgM HEV

  50. Acute viral hepatitis: Case classification • Suspect • As per clinical definition • Confirmed • A suspect case that is laboratory confirmed • For hepatitis A/E, a case compatible with the clinical description and with epidemiological link with a laboratory confirmed case of hepatitis A/E.

More Related